Polypoidal choroidal vasculopathy-characteristics and response to treatment with bevacizumab in caucasian patients.
Fidaa El ZhalkaElad MoisseievAlexander RubowitzPublished in: International journal of retina and vitreous (2022)
Fixed first-line treatment with intravitreal bevacizumab monotherapy in non-Asian PCV patients achieves satisfactory visual and anatomical outcomes.